Quantum-Si to Participate in B. Riley Securities Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference

QSI Stock  USD 1.14  0.11  8.80%   
Under 57% of QuantumSi's investor base is looking to short. The analysis of the overall investor sentiment regarding QuantumSi suggests that many traders are alarmed. QuantumSi's investing sentiment shows overall attitude of investors towards QuantumSi.
  
Quantum-Si to Participate in B. Riley Securities Life Sciences Tools Conference

Read at businesswire.com
businesswire News
  

QuantumSi Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards QuantumSi can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

QuantumSi Fundamental Analysis

We analyze QuantumSi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QuantumSi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QuantumSi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

QuantumSi is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

QuantumSi Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with QuantumSi stock to make a market-neutral strategy. Peer analysis of QuantumSi could also be used in its relative valuation, which is a method of valuing QuantumSi by comparing valuation metrics with similar companies.

Peers

QuantumSi Related Equities

VERVVerve Therapeutics   27.63   
0%
100.0%
MNOVMediciNova   14.98   
0%
54.0%
HCWBHCW Biologics   8.51   
0%
30.0%
CRBUCaribou Biosciences   8.22   
0%
29.0%
CRSPCrispr Therapeutics   7.78   
0%
28.0%
PRMEPrime Medicine,   4.86   
0%
17.0%
ABOSAcumen Pharmaceuticals   3.52   
0%
12.0%
BEAMBeam Therapeutics   3.40   
0%
12.0%
HRTXHeron Therapeuti   2.52   
0%
9.0%
SEERSeer   2.43   
0%
8.0%
HOOKHookipa Pharma   2.38   
0%
8.0%
NTLAIntellia Therapeutics   0.70   
0%
2.0%
EDITEditas Medicine   2.23   
8.0%
0%
BDTXBlack Diamond   2.26   
8.0%
0%
NRIXNurix Therapeutics   2.80   
10.0%
0%
ALECAlector   3.09   
11.0%
0%
RNAAvidity Biosciences   4.02   
14.0%
0%
PASGPassage Bio   10.62   
38.0%
0%

Complementary Tools for QuantumSi Stock analysis

When running QuantumSi's price analysis, check to measure QuantumSi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuantumSi is operating at the current time. Most of QuantumSi's value examination focuses on studying past and present price action to predict the probability of QuantumSi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuantumSi's price. Additionally, you may evaluate how the addition of QuantumSi to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities